Cargando…
Reduction of Traumatic Brain Damage by Tspo Ligand Etifoxine
Experimental studies have shown that ligands of the 18 kDa translocator protein can reduce neuronal damage induced by traumatic brain injury by protecting mitochondria and preventing metabolic crisis. Etifoxine, an anxiolytic drug and 18 kDa translocator protein ligand, has shown beneficial effects...
Autores principales: | Shehadeh, Mona, Palzur, Eilam, Apel, Liat, Soustiel, Jean Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600152/ https://www.ncbi.nlm.nih.gov/pubmed/31146356 http://dx.doi.org/10.3390/ijms20112639 |
Ejemplares similares
-
Etifoxine Restores Mitochondrial Oxidative Phosphorylation and Improves Cognitive Recovery Following Traumatic Brain Injury
por: Palzur, Eilam, et al.
Publicado: (2021) -
Etifoxine, a TSPO Ligand, Worsens Hepatitis C-Related Insulin Resistance but Relieves Lipid Accumulation
por: Lin, Yu-Min, et al.
Publicado: (2019) -
Translocator Protein Ligand Etifoxine Attenuates MPTP-Induced Neurotoxicity
por: Tian, Qi, et al.
Publicado: (2022) -
Etifoxine for Pain Patients with Anxiety
por: Choi, Yun Mi, et al.
Publicado: (2015) -
Differential effects of the translocator protein 18 kDa (TSPO) ligand etifoxine and the benzodiazepine alprazolam on startle response to predictable threat in a NPU-threat task after acute and short-term treatment
por: Brunner, Lisa-Marie, et al.
Publicado: (2022)